|
1
|
Chobanian AV, Bakris GL, Black HR, et al:
The seventh report of the Joint National Committee on prevention,
detection, evaluation, and treatment of high blood pressure: the
JNC 7 report. JAMA. 289:2560–2572. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Elderen SG, Brandts A, van der Grond
J, Westenberg JJ, Kroft LJ, van Buchem MA, Smit JW and de Roos A:
Cerebral perfusion and aortic stiffness are independent predictors
of white matter brain atrophy in type 1 diabetic patients assessed
with magnetic resonance imaging. Diabetes Care. 34:459–463. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Elderen SG, Westenberg JJ, Brandts A,
van der Meer RW, Romijn JA, Smit JW and de Roos A: Increased aortic
stiffness measured by MRI in patients with type 1 diabetes mellitus
and relationship to renal function. AJR Am J Roentgenol.
196:697–701. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tomiyasu M, Aida N, Endo M, Shibasaki J,
Nozawa K, Shimizu E, Tsuji H and Obata T: Neonatal brain metabolite
concentrations: An in vivo magnetic resonance spectroscopy study
with a clinical MR system at 3 Tesla. PLoS One. 8:1–7. 2013.
View Article : Google Scholar
|
|
5
|
Yildiz-Yesiloglu A and Ankerst DP:
Neurochemical alterations of the brain in bipolar disorder and
their implications for pathophysiology: a systematic review of the
in vivo proton magnetic resonance spectroscopy findings. Prog
Neuropsychopharmacol Biol Psychiatry. 30:969–995. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schaeffter T and Dahnke H: Magnetic
resonance imaging and spectroscopy. Molecular Imaging. Handb Exp
Pharmacol. 185:75–90. 2008. View Article : Google Scholar
|
|
7
|
Tate AR, Griffiths JR, Martínez-Pérez I,
Moreno A, Barba I, Cabañas ME, Watson D, Alonso J, Bartumeus F,
Isamat F, et al: Towards a method for automated classification of
1H MRS spectra from brain tumours. NMR Biomed. 11:177–191. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vicente J, Fuster-Garcia E, Tortajada S,
García-Gómez JM, Davies N, Natarajan K, Wilson M, Grundy RG,
Wesseling P, Monleón D, et al: Accurate classification of childhood
brain tumours by in vivo ¹H MRS a multi centre study. Eur J Cancer.
49:658–667. 2013. View Article : Google Scholar
|
|
9
|
Sinha S, Ekka M, Sharma U, P R, Pandey RM
and Jagannathan NR: Assessment of changes in brain metabolites in
Indian patients with type-2 diabetes mellitus using proton magnetic
resonance spectroscopy. BMC Res Notes. 7:412014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sahin I, Alkan A, Keskin L, Cikim A,
Karakas HM, Firat AK and Sigirci A: Evaluation of in vivo cerebral
metabolism on proton magnetic resonance spectroscopy in patients
with impaired glucose tolerance and type 2 diabetes mellitus. J
Diabetes Complications. 22:254–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang M, Sun X, Zhang Z, Meng Q, Wang Y,
Chen J, Ma X, Geng H and Sun L: Brain metabolite changes in
patients with type 2 diabetes and cerebral infarction using proton
magnetic resonance spectroscopy. Int J Neurosci. 124:37–41. 2014.
View Article : Google Scholar
|
|
12
|
Hajek T, Calkin C, Blagdon R, Slaney C and
Alda M: Type 2 diabetes mellitus: A potentially modifiable risk
factor for neurochemical brain changes in bipolar disorders. Biol
Psychiatry. 87:295–303. 2015. View Article : Google Scholar
|
|
13
|
Catani M, Mecocci P, Tarducci R, Howard R,
Pelliccioli GP, Mariani E, Metastasio A, Benedetti C, Senin U and
Cherubini A: Proton magnetic resonance spectroscopy reveals similar
white matter biochemical changes in patients with chronic
hypertension and early Alzheimer’s disease. J Am Geriatr Soc.
50:1707–1710. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ben Salem D, Walker PM, Bejot Y, Aho SL,
Tavernier B, Rouaud O, Ricolfi F and Brunotte F:
N-acetylaspartate/creatine and choline/creatine ratios in the
thalami, insular cortex and white matter as markers of hypertension
and cognitive impairment in the elderly. Hypertens Res.
31:1851–1857. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davis BR, Vogt T, Frost PH, Burlando A,
Cohen J, Wilson A, Brass LM, Frishman W, Price T and Stamler J:
Risk factors for stroke and type of stroke in persons with isolated
systolic hypertension. Systolic Hypertension in the Elderly Program
Cooperative Research Group. Stroke. 29:1333–1340. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Djelilovic-Vranic J, Alajbegovic A,
Zelija-Asimi V, Niksic M, Tiric-Campara M, Salcic S and Celo A:
Predilection role diabetes mellitus and dyslipidemia in the onset
of ischemic stroke. Med Arch. 67:120–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hägg S, Thorn LM, Putaala J, Liebkind R,
Harjutsalo V, Forsblom CM, Gordin D and Tatlisumak T; Groop PH
FinnDiane Study Group: Incidence of stroke according to presence of
diabetic nephropathy and severe diabetic retinopathy in patients
with type 1 diabetes. Diabetes Care. 36:4140–4146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanaka R, Ueno Y, Miyamoto N, Yamashiro K,
Tanaka Y, Shimura H, Hattori N and Urabe T: Impact of diabetes and
prediabetes on the short-term prognosis in patients with acute
ischemic stroke. J Neurol Sci. 332:45–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van Bilsen M, Daniels A, Brouwers O,
Janssen BJ, Derks WJ, Brouns AE, Munts C, Schalkwijk CG, van der
Vusse GJ and van Nieuwenhoven FA: Hypertension is a conditional
factor for the development of cardiac hypertrophy in type 2
diabetic mice. PLoS One. 9:e850782014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakagawa T: A new mouse model resembling
human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel
pathogenic mechanism. Clin Nephrol. 71:103–109. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baldwin MD: Assessing cardiovascular risk
factors and selecting agents to successfully treat patients with
type 2 diabetes mellitus. J Am Osteopath Assoc. 111:S2–S12.
2011.PubMed/NCBI
|
|
22
|
Bruzzone MG, D’Incerti L, Farina LL,
Cuccarini V and Finocchiaro G: CT and MRI of brain tumors. Q J Nucl
Med Mol Imaging. 56:112–137. 2012.PubMed/NCBI
|
|
23
|
Law M: Advanced imaging techniques in
brain tumors. Cancer Imaging. 9:S4–S9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moffett JR, Ross B, Arun P, Madhavarao CN
and Namboodiri AM: N-Acetylaspartate in the CNS: from
neurodiagnostics to neurobiology. Prog Neurobiol. 81:89–131. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szulc A: First and second generation
antipsychotics and morphological and neurochemical brain changes in
schizophrenia. Review of magnetic resonance imaging and proton
spectroscopy findings. Psychiatr Pol. 41:329–338. 2007.In Polish.
PubMed/NCBI
|
|
26
|
Kario K, Ishikawa J, Hoshide S, Matsui Y,
Morinari M, Eguchi K, Ishikawa S and Shimada K: Diabetic brain
damage in hypertension: role of renin-angiotensin system.
Hypertension. 45:887–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eguchi K, Pickering TG and Kario K: Why is
blood pressure so hard to control in patients with type 2 diabetes?
J Cardiometab Syndr. 2:114–118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kreis R, Ross BD, Farrow NA and Ackerman
Z: Metabolic disorders of the brain in chronic hepatic
encephalopathy detected with H-1 MR spectroscopy. Radiology.
182:19–27. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kreis R and Ross BD: Cerebral metabolic
disturbances in patients with subacute and chronic diabetes
mellitus: detection with proton MR spectroscopy. Radiology.
184:123–130. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shiino A, Watanabe T, Shirakashi Y, Kotani
E, Yoshimura M, Morikawa S, Inubushi T and Akiguchi I: The profile
of hippocampal metabolites differs between Alzheimer’s disease and
subcortical ischemic vascular dementia, as measured by proton
magnetic resonance spectroscopy. J Cereb Blood Flow Metab.
32:805–815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ciobanu AO, Gherghinescu CL, Dulgheru R,
Magda S, Dragoi Galrinho R, Florescu M, Guberna S, Cinteza M and
Vinereanu D: The impact of blood pressure variability on
subclinical ventricular, renal and vascular dysfunction, in
patients with hypertension and diabetes. Maedica (Buchar).
8:129–136. 2013.
|
|
32
|
Heiss WD, Hartmann A, Rubi Fessen I,
Anglade C, Kracht L, Kessler J, Weiduschat N, Rommel T and Thiel A:
Noninvasive brain stimulation for treatment of right and left
handed poststroke aphasics. Cerebrovasc Dis. 36:363–372. 2013.
View Article : Google Scholar
|
|
33
|
Hang L, Friedman J, Ernst T, Zhong K,
Tsopelas ND and Davis K: Brain metabolite abnormalities in the
white matter of elderly schizophrenic subjects: implication for
glial dysfunction. Biol Psychiatry. 62:1396–1404. 2007. View Article : Google Scholar
|
|
34
|
Abdel Razek AA and Poptani H: MR
spectroscopy of head and neck cancer. Eur J Radiol. 82:982–989.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takenaka S, Shinoda J, Asano Y, Aki T,
Miwa K, Ito T, Yokoyama K and Iwama T: Metabolic assessment of
monofocal acute inflammatory demyelination using MR spectroscopy
and (11)C-methionine, (11)C-choline-, and
(18)F-fluorodeoxyglucose-PET. Brain Tumor Pathol. 28:229–238. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mellergård J, Tisell A, Dahlqvist Leinhard
O, Blystad I, Landtblom AM, Blennow K, Olsson B, Dahle C, Ernerudh
J, Lundberg P and Vrethem M: Association between change in normal
appearing white matter metabolites and intrathecal inflammation in
natalizumab-treated multiple sclerosis. PLoS One. 7:1–9. 2012.
View Article : Google Scholar
|
|
37
|
Liu LL, Yan L, Chen YH, Zeng GH, Zhou Y,
Chen HP, Peng WJ, He M and Huang QR: A role for diallyl trisulfide
in mitochondrial antioxidative stress contributes to its protective
effects against vascular endothelial impairment. Eur J Pharmacol.
14:11–19. 2014.
|
|
38
|
Danyel LA, Schmerler P, Paulis L, Unger T
and Steckelings UM: Impact of AT2-receptor stimulation on vascular
biology, kidney function, and blood pressure. Integr Blood Press
Control. 6:153–161. 2013.
|
|
39
|
Fukasawa R, Hanyu H, Namioka N, Hatanaka
H, Sato T and Sakurai H: Elevated inflammatory markers in
diabetes-related dementia. Geriatr Gerontol Int. 14:229–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
